$1.7 Million NIH Grant to Fund Pain Therapeutics’ Study of PTI-125 as Candidate for Alzheimer’s Treatment
Otsuka and Avanir to Help Start an Alzheimer’s Assistants Training Program in New Jersey
June 1, 2017
Phase 1 Trial Begins Evaluating Safety of Focused Ultrasound in Alzheimer’s Patients
June 7, 2017
The National Institutes of Health (NIH) has awarded Pain Therapeutics a $1.7 million research grant to study PTI-125 as a potential treatment for Alzheimer’s disease.
